Background: Pemphigus is frequently diagnosed via indirect immunofluorescence (IIF) or skin biopsy with direct immunofluorescence staining. However, the accuracy of IIF to detect anti-intercellular substance autoantibodies (anti-ICS Ab) has not been evaluated in Asian populations. Method: IIF was performed on 177 patient samples. Demographic data and underlying diseases were analyzed. Histopathology and direct immunofluorescence results were also reviewed. The false-positive group included 45 patients without pemphigus but with positive ICS Ab results. The other groups included true-negative (116 patients without pemphigus and negative ICS Ab results), true-positive (14 pemphigus patients with positive ICS Ab results), and false-negative (two pemphigus patients with negative ICS Ab results) results. Univariate and multivariate analysis were performed to exam the factors associated with false positivity. Results: Anti-ICS Ab detected using IIF has been shown in 87.5% of patients with confirmed pemphigus. The specificity of IIF on pemphigus was 72.1%. The positive and negative predictive rates were 23.7% and 98.3%, respectively. The false positive rate was 25.4% (n ¼ 45/177). The titers of the false positive results were 1:20, 1:40, and 1:80, in 28, 10, and 7 patients, respectively. The false-positive results also diminished during sequential follow-ups in some patients after treatments. There was higher rates of patients with blood type O (66.7% vs. 36.3%; p ¼ 0.02) and bullous pemphigoid (31% vs. 15%; p ¼ 0.05) in the falsepositive group, compared with the rest of the population. In the adjusted analysis, blood type O was found to be significantly associated with a false-positive IIF results when compared with blood types A and B. Conclusion: This study provided practical statistics for the accuracy of anti-ICS IIF tests. Due to the high false-positive rate and low positive-predictive rate, the results of anti-ICS IIF for pemphigus diagnosis should be carefully interpreted.
Background
Pemphigus is a potentially fatal autoimmune blistering disease caused by immunoglobulin G (IgG) autoantibodies against desmoglein (Dsg)3 (a 130-kDa protein) and Dsg1 (a 160-kDa protein), leading to the destruction of cellecell adhesions between stratified keratinocytes. 1, 2 The diagnosis of pemphigus relies on histological findings of intraepidermal acantholysis and immunofluorescence studies documenting the presence of skin autoantibodies, either via direct immunofluorescence (DIF) of perilesional skin, indirect immunofluorescence (IIF), or enzyme-linked immunosorbent assay (ELISA) analysis of patients' sera. 3, 4 Positive immunofluorescent intercellular substance (ICS) staining is characterized by the deposition of IgG along the epithelium in a pattern reminiscent of chicken wire. 3, 4 Conflicts of interest: The authors declare that they have no financial or nonfinancial conflicts of interest related to the subject matter or materials discussed in this article.
However, DIF or ELISA for diagnosing pemphigus may not be available in all medical facilities, and thus, IIF for anti-ICS autoantibodies (anti-ICS Ab) may be the most common clinical test. However, in clinical practice, the interpretation of both positive and negative results of this indirect test may be complicated. The documented sensitivity of anti-ICS IIF in patients with pemphigus ranges from 81% to 90%, 5e8 and the observed variance is because of the use of substrates such as monkey and guinea pig esophagus. 5, 6, 9, 10 In addition, concurrent autoimmune disorders, burns, infections, and even blood types have been reported to lead to false-positive test results in a few studies. 11e14 Although monkey esophagus is a common commercial substrate for anti-ICS Ab screening, the accuracy of this test in Asian populations is currently unknown. In addition, studies have not thoroughly explored whether age, sex, concurrent diseases, or other factors, such as blood type, may interfere with the test results. Furthermore, the potential of IIF persistence is also unknown. Therefore, this study investigated the specificity and sensitivity of anti-ICS and the factors associated with the accuracy of this diagnostic method.
Materials and methods

Patients
Patients tested for serum anti-ICS Ab with IIF between May 2012 and December 2014 at Wan Fang Hospital in Taiwan were subjected to a retrospective review. Given the rarity of pemphigus, all the pemphigus patients in the past decade diagnosed using both IIF and DIF results were included. Demographics, blood type, laboratory data, pathology reports, and medical histories of underlying diseases were collected. These patients underwent the tests to confirm suspicion regarding autoimmune blistering diseases. A false-positive result was defined as a positive IIF result for anti-ICS Ab but a failure of the histo-or immuno-pathological evidence or clinical course to indicate pemphigus rather than other diseases. Patients in the "true negative" group had both negative IIF results and a clear exclusion of pemphigus because of other suggestive diagnoses and a lack of evidence of pemphigus.
Statistics
The summarized statistical results of the baseline characteristics of all patients are expressed as percentages for categorical data and means ± standard deviations for continuous variables. Means were compared using an independent t-test analysis of variance. Categorical data were assessed using the Chi-square test. Sensitivity, specificity, and positive and negative predictive values were also determined. A multivariate logistic regression was used to assess the factors associated with false positivity. A p-value of <0.05 was considered statistically significant. PASW Statistics for Windows, Version 18.0. (Chicago: SPSS Inc. Released 2009) was used for statistical analysis.
Results
A total of 177 patients, including 101 women (57.1%) and 76 (42.9%) men were enrolled in the study ( Table 1 (Table 1) . False-negative IIF results were also observed in two patients diagnosed with PV and PF, respectively. The sensitivity, specificity, and positive and negative predictive values of the IIF test for pemphigus were 87.5% [95% confidence interval (CI): 61.6e98.5%], 72.1% (95% CI: 64.4e78.8%), 23.7% (95% CI: 13.6e36.6%), and 98.3% (95% CI: 94.1e99.8%) using a standard cutoff titer of 1:20. These four values were 68.8% (95% CI: 41.3e88.9%), 89.4% (95% CI: 83.6e93.7%), 39.3% (95% CI: 21.5e59.4%), and 96.6% (95% CI: 92.3e98.9%) with the cut-off point at 1:40. With a cut-off titer taken at 1:80, the sensitivity decreased to 56.3 (95% CI: 29.9e80.3%) and the rest of the indicants were 95.6% (95% CI: 91.3e98.2%), 56.3% (95% CI: 29.9e80.3%), and 95.7% (95% CI: 91.3e98.2%), respectively.
The persistence of false-positive IIF test results was unknown according to literature. In our study, four patients had false-positive ICS staining at a titer of 1:20 (two patients with urticaria and angioedema, and two with eczema and underlying sicca syndrome). Another patient who was eventually diagnosed with bullous scabies presented with a false-positive staining titer of 1:40, and one patient with eczema and underlying sicca syndrome presented with a false-positive staining titer of 1:80. The follow-up IIF test results of these patients were all negative at 3e6 months after treatment and stabilization of the skin conditions.
The patients were divided into two groups according to their IIF test results: the "false-positive" group (n ¼ 45) and the "others" group (n ¼ 132). These groups did not differ significantly in terms of the mean age and sex distribution ( Table 1) . The "false-positive" group had a significantly higher proportion of patients with blood type O than the "others" group (66.7% vs. 36.3%; p ¼ 0.022). More patients in the "false-positive" group were diagnosed with BP (31.1% vs. 15.1%; p ¼ 0.055) than in the rest of the population. No significant differences were observed in the proportions of patients with eczema, urticaria, drug hypersensitivity, bullous scabies, or other dermatological diseases between the groups (Table 1) .
A multivariate logistic regression was performed ( esophagus, and rates of 79% for PV and 84% for PF when using human skin. Rabbit esophagus has also been used in IIF testing for pemphigus although this is less common. 16 In general, monkey esophagus, which is rich in Dsg3, is more sensitive for PV antibody detection. 6, 15 Guinea pig esophagus and normal human skin, which are rich in Dsg1, are considered superior substrates for IIF screening to detect PF antibodies. 6, 10, 15, 17 Specificity, however, has been less frequently discussed in literature. The specificity of the IIF test in this study was relatively low (72%), and false-positive results were achieved for 45 patients. In clinical practice, IIF is used when considering a diagnosis of pemphigus, and the interpretation of positive anti-ICS Ab staining by IIF may be complicated. In our current study, the control participants were 161 patients with skin manifestations indicating suspected autoimmune bullous dermatoses for which pemphigus had subsequently been excluded as a possible diagnosis, rather than healthy individuals. Zagorodniuk et al 7 compared 50 healthy people or patients with unrelated skin disorders to 38 pemphigus patients. In the previous study, the IIF test results were negative for all 50 controls, indicating a specificity of 100%. Cunha et al 8 also
recruited 15 healthy workers as controls and as expected, failed to detect anti-ICS Ab using IIF in these individuals. However, Ahmed and Workman 11 reported that 14 of 1500 patients (0.9%) subjected to IIF serum analysis had false-positive intercellular IgG deposition results. In our study, 45 of the 177 patients (25.4%) had falsepositive resultsda much higher rate than previously reported. The specificity of this test was also less favorable. Among the patients with false-positive anti-ICS IIF test results, 31.1% were diagnosed with BP. In previous reports, false-positive anti-ICS Ab results were mostly observed in patients with other autoimmune disorders associated with the potential production of pemphigus-like autoantibodies including BP, cicatricial pemphigoid, epidermolysis bullosa acquisita, and systemic lupus erythematosus. 11, 12, 14, 18 In addition, epidermal antigens might be released by burns, extensive scratching, infections, and biochemical insults (e.g., drugs) that cause the exposure of antigens to the immune system and subsequently induce anti-ICS Ab production. 11, 13, 19 Therefore, the presence of these antibodies might be transient and undetectable after skin recovery, as observed in our patients with negative follow-up results after initial positive results. The most common blood type in our cohort was O (44.1%), followed by A (26.5%), B (25.9%), and AB (3.3%). This distribution was compatible with the frequencies of blood types A, B, O, and AB among general blood donors as 26.7%, 23.8%, 43.6%, and 5.9% from the Taiwan Blood Services Foundation, which differed from the distribution in other racial/ethnic populations. 20 In the adjusted analysis, blood type O was associated with a higher rate of falsepositive IIF results than blood types A and B were. This finding might be attributable to cross-reactivity between blood-group antigen-specific antibodies and the ICS. 21 IgM, IgG, or IgA class antibodies may be directed against the human A and B blood group antigens. Some sera contain all three classes, and although nonstimulated individuals are predominantly IgM, isotype switching to IgG may occur due to genetic and environmental factors. 22, 23 An encounter between blood group antibodies and their antigenic targets on primate-derived substrates could lead to a pemphiguslike test pattern. However, differences between pemphigusrelated and group A/B red-cell antibody-related staining patterns have been reported. 24, 25 Anti-A and anti-B IgG iso-antibody-related staining tends to spare the intercellular spaces of the basal layer and thus yields a coarser appearance, whereas true-positive staining tends to be sharper and more defined. 24, 25 This effect could be abolished via absorption with purified A and B antigens in solution. 11 Similar findings were reported in some patients with symptoms of sicca but no other autoimmune features. 26 In a previous study, 12 of 13 patients whose sera exhibited antisalivary duct autoantibody-like staining had the O blood type. 26 In that study, ductal-pattern staining was abolished after absorption with blood group AB erythrocytes or antigens. 26 Isotype-switched IgG AB blood group antibodies might cross-react not only with primate epithelial ICS, but also with salivary ducts, leading to false-positive test results. In addition, a high frequency of immune ABO antibodies (69%) has been reported in group O Thai blood donors. 27 Moreover, a high frequency of IgG anti-A and anti-B hemolysins was reported in Asian and African-American populations, relative to that in Caucasians. 22 This discrepancy might also explain the higher rate of false-positivity in the present Taiwanese cohort. However, data from a blood transplant donor population indicated that only 13% had high anti-A or -B Ab titers (>100). 28 This finding might explain why false-positive anti-ICS IIF test results were not obtained for all patients with blood type O. As this study involved an observational cohort, our ability to elucidate definite links was limited. Despite the rather limited sample size, the findings corresponded to the generally low incidence of pemphigus and reflected the diagnostic challenge encountered in daily practice. In addition, an ELISA was not performed due to its unavailability in the clinical laboratory. Furthermore, selection bias might exist with regard to the fact that patients underwent testing based on a physician's clinical judgment. However, the study design was based on a common clinical setting. The patients were recruited at a single center, which comprises another limitation and might lead to a suspicion that the high false-positive rate was related to laboratory bias at this center. However, sera from the patients were sent to the Taipei Institute of Pathology, an institute that uses the same commercial kits, standard techniques, and professional technicians to process anti-ICS IIF tests referred from several hospitals in Taipei.
